Guardian Pharmacy shares rise 3% in lukewarm NYSE debut
Sept 26 (Reuters) - Guardian Pharmacy's GRDN.N shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million. (Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Shreya Biswas ) ((JaiveerSingh.Shekhawat@thomsonreuters.com;))
Recent news on Guardian Pharmacy Services
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Guardian Pharmacy Services Acquires Assets Of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services, Inc. reports results for the quarter ended June 30 - Earnings Summary
Guardian Pharmacy Q2 revenue beats estimates; 2026 outlook lifted
Brief: Guardian Pharmacy Services Expands Virginia Footprint With Acquisition Of Wellness Concepts